Hoth Therapeutics Partners With OnTargetX to Advance HT-KIT Cancer Therapy

Hoth Therapeutics, a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, announced its collaboration with OnTargetx R&D Inc. to advance research for its cancer-fighting therapeutic, HT-KIT. This immunohistochemistry...

Download the Health Technology Insights Media Kit

Access audience insights, traffic stats, and partnership opportunities in one comprehensive media kit